The Food and Drug Administration announced a new approved use for the drug leucovorin, a synthetic form of vitamin B9 that the Trump administration has touted as a treatment for autism symptoms.

But the new approval is not for autism — it’s for cerebral folate deficiency, a rare neurological condition characterized by low levels of vitamin B9 in the brain.